PCRX News
Pacira BioSciences, Inc.
$36.40
+$0.09(+0.25%)
69
Overall
60
Value
83
Tech
65
Quality
Market Cap
$1.45B
Volume
2.33M
52W Range
$18.80 - $36.46
Target Price
$32.00
PCRX news: the latest Pacira BioSciences, Inc. headlines, press releases and market updates, newest first.
Latest PCRX News
- PharmaCorp Rx Appoints New CFO to Drive Pharmacy Acquisition StrategyTipRanks Canadian Auto-Generated Newsdesk · Oct 14, 2026
- Pacira Pharmaceuticals (PCRX) Gets a Hold from Leerink PartnersTipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Pacira Pharmaceuticals (PCRX) and Brookdale Senior Living (BKD)TipRanks Newsroom · Oct 9, 2026
- Why Is Pacira Pharmaceuticals Stock (PCRX) Up 44% Today?William White · Oct 8, 2026
- Pacira to be acquired by Viatris in cash dealTipRanks Auto-Generated Newsdesk · Oct 8, 2026
- Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Pacira Pharmaceuticals (PCRX)TipRanks Newsroom · Oct 5, 2026
- PharmaCorp Expands Pharmacy Network and Boosts Acquisition FinancingTipRanks Canadian Auto-Generated Newsdesk · Oct 1, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PCRX | $36.40 | +0.2% | 2.33M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Pacira BioSciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW